(Q34345032)

English

Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

D Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Y Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Y Gu

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

W Fan

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

67

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

585-594

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Projections of US prevalence of arthritis and associated activity limitations

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Osteoarthritis: rational approach to treating the individual

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Generation of allocation sequences in randomised trials: chance, not choice

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Meta-analysis: formulating, evaluating, combining, and reporting

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Non-human primates as a model for reproductive aging and human infertility

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

The effect of glucosamine supplementation on people experiencing regular knee pain.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Crystalline glucosamine sulfate in the treatment of osteoarthritis: evidence of long-term cardiovascular safety from clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure-modifying drug trials

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure-modifying drug trials

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine sulfate in osteoarthritis of the knee.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine therapy for treating osteoarthritis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine for pain in osteoarthritis: why do trial results differ?

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12115

21 January 2018

Identifiers

10.1111/IJCP.12115

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34345032&oldid=1963990208"